Filing Details
- Accession Number:
- 0001708138-17-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-23 16:10:08
- Reporting Period:
- 2017-06-21
- Filing Date:
- 2017-06-23
- Accepted Time:
- 2017-06-23 16:10:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487767 | S Michael Aberman | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Strategy Investor Relation | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-21 | 4,500 | $30.63 | 9,193 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-21 | 270 | $510.02 | 8,923 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-06-21 | 1,961 | $510.02 | 6,962 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-06-22 | 395 | $525.21 | 6,567 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 100 | $526.02 | 6,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 100 | $529.61 | 6,367 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 100 | $530.66 | 6,267 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 274 | $531.51 | 5,993 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 200 | $532.27 | 5,793 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 200 | $533.48 | 5,593 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 200 | $534.51 | 5,393 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 400 | $536.52 | 4,993 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 100 | $537.50 | 4,893 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 100 | $538.30 | 4,793 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-22 | 100 | $541.00 | 4,693 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-06-21 | 4,500 | $0.00 | 4,500 | $30.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,000 | 2020-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 11,805 | Indirect | by GRAT |
| Common Stock | 448 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 395 shares of Company stock on June 22, 2017 at prices ranging from $525.00 to $525.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- Represents volume-weighted average price of sales of 274 shares of Company stock on June 22, 2017 at prices ranging from $531.05 to $531.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on June 22, 2017 at prices ranging from $532.18 to $532.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on June 22, 2017 at prices ranging from $533.17 to $533.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on June 22, 2017 at prices ranging from $534.16 to $534.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- Represents volume-weighted average price of sales of 400 shares of Company stock on June 22, 2017 at prices ranging from $536.15 to $536.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 22, 2017 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
